ILIAS Biologics Inc.
PrivateLast Round
Series B
Sep 28, 2020
Total Funding Raised
$50.89M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ILIAS Biologics Inc. is a biotechnology company that develops exosome-based therapeutics for inflammatory and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ILIAS Biologics Inc. Comparables
Compare ILIAS Biologics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SHIFTBIO | 86% | |
| Carus Bio | 85% | |
| ExoStemTech | 84% |
ILIAS Biologics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 28, 2020 | ||||
| Series A | May 1, 2018 |
ILIAS Biologics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KIWOOM Securities Co., Ltd. | Series B |
| Genie Asset Management | Series B |
| Meritz Securities Co., Ltd. | Series B |
| Timefolio Asset Management | Series A, Series B |
| Daedeok Venture Partners | Series A, Series B |
| HB Investment | Series A, Series B |
| Devsisters Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 125% MoM.
- Jul 20, 2026
Open roles increased from 0 to 9, representing 53% of headcount.
ILIAS Biologics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ILIAS Biologics Inc.'s valuation, stock price, and market status.
Is ILIAS Biologics Inc. a public or private company?
ILIAS Biologics Inc. is a private company.
What is the current stock price of ILIAS Biologics Inc.?
ILIAS Biologics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is ILIAS Biologics Inc. worth (valuation)?
Valuation information for ILIAS Biologics Inc. is not publicly available.
Can I buy ILIAS Biologics Inc. stock?
ILIAS Biologics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ILIAS Biologics Inc.'s last funding round?
ILIAS Biologics Inc.'s most recent funding round was Series B on September 28, 2020.
Who are the main investors in ILIAS Biologics Inc.?
Key investors in ILIAS Biologics Inc. include KIWOOM Securities Co., Ltd., Genie Asset Management, Meritz Securities Co., Ltd., Timefolio Asset Management, Daedeok Venture Partners.
Will ILIAS Biologics Inc. IPO soon?
No public IPO plans have been announced for ILIAS Biologics Inc..
How can I track ILIAS Biologics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ILIAS Biologics Inc.'s secondary market activity and sign up for updates.